Vaccine Rhiniseng
| Species | Swine. |
|---|---|
| Composition |
Each 2 ml dose contains: Active substances: (*) Number of *Bordetella bronchiseptica* cells in log10. Adjuvants: Excipients: White homogeneous suspension. |
| Indications |
For the passive protection of piglets through colostrum ("first milk") after active immunization of sows and gilts to reduce clinical signs and lesions caused by progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with infections with Bordetella bronchiseptica and Pasteurella multocida during the fattening period. Control infection studies have shown that passive immunity lasts until piglets reach 6 weeks of age, while clinical field studies have observed the beneficial effects of vaccination (reduction in nasal lesions and weight loss) until slaughter. |
| Dosage and method of administration |
Intramuscular use. Administer one dose (2 ml) by intramuscular injection into the muscles of the neck and according to the following schedule: Basic vaccination: sows and gilts not previously vaccinated with the product should be given two injections at an interval of 3-4 weeks. The first injection should be administered 6-8 weeks before the expected calving date. Revaccination: a single injection should be given 3-4 weeks before each subsequent calving. Before administration, the vaccine must reach room temperature (15-25˚C). Shake well before use. |
| Contraindications | Do not use in case of hypersensitivity to the active substances, adjuvants or any of the excipients. |
| Waiting period |
Zero days. |
| Release form |
Packaging dimensions: - Cardboard box with 1 or 10 PET vials with 10 doses. |
| Storage conditions |
Keep out of the sight and reach of children. Shelf life after first opening the primary packaging: 10 hours, stored at 15 °C - 25 °C. |
| Shelf life |
2 years from the date of production. Do not use after the expiry date indicated on the packaging. |
